Cardiovascular manifestations and treatment considerations in COVID-19

Yu Kang1, Tiffany Chen1, David Mui2

  • 1Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Insights

COVID-19 significantly increases the risk of severe illness and death, particularly in patients with pre-existing cardiovascular conditions. The virus also directly causes various cardiac complications, necessitating specific management strategies.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 (coronavirus disease 2019) pandemic has led to widespread global health challenges.
  • Pre-existing comorbidities like hypertension, diabetes, and cardiovascular disease (CVD) are linked to increased COVID-19 severity and mortality.
  • COVID-19 is recognized to precipitate acute cardiovascular complications, mirroring effects seen in other viral respiratory illnesses.

Purpose of the Study:

  • To outline the significant cardiovascular complications associated with COVID-19.
  • To highlight the similarities between COVID-19 and other viral infections regarding cardiovascular impact.
  • To discuss essential cardiovascular considerations in the supportive management of COVID-19 patients.

Main Methods:

  • Review of current literature on COVID-19 and cardiovascular complications.
  • Analysis of clinical data linking comorbidities to COVID-19 outcomes.
  • Examination of therapeutic strategies for managing cardiac issues in COVID-19.

Main Results:

  • COVID-19 is associated with increased severity and fatality in patients with hypertension, diabetes, and CVD.
  • Reported cardiovascular complications include acute myocardial injury, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest.
  • Cardiovascular interactions of COVID-19 share similarities with SARS, MERS, and influenza.

Conclusions:

  • COVID-19 poses a substantial threat to cardiovascular health, exacerbating existing conditions and causing new cardiac problems.
  • Management requires careful consideration of anticoagulation, renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, and circulatory support.
  • Understanding these cardiovascular interactions is crucial for optimizing patient care during the pandemic.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
241
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
117
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
291
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
227
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
156
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219